C. Kent Kwoh, Wei-Hsuan Lo-Ciganic, Hao Helen Zhang, Julie M. Donohue, James L. Huang, Yonghui Wu, Adam J. Gordon, Gerald Cochran, Daniel C. Malone, Walid F. Gellad, Jeremy C. Weiss, and Courtney C. Kuza
Key Points Question Can machine-learning approaches predict opioid overdose risk among fee-for-service Medicare beneficiaries? Findings In this prognostic study of the administrative claims data of 560 057 Medicare beneficiaries, the deep neural network and gradient boosting machine models outperformed other methods for identifying risk, although positive predictive values were low given the low prevalence of overdose episodes. Meaning Machine-learning algorithms using administrative data appear to be a valuable and feasible tool for more accurate identification of opioid overdose risk., Importance Current approaches to identifying individuals at high risk for opioid overdose target many patients who are not truly at high risk. Objective To develop and validate a machine-learning algorithm to predict opioid overdose risk among Medicare beneficiaries with at least 1 opioid prescription. Design, Setting, and Participants A prognostic study was conducted between September 1, 2017, and December 31, 2018. Participants (n = 560 057) included fee-for-service Medicare beneficiaries without cancer who filled 1 or more opioid prescriptions from January 1, 2011, to December 31, 2015. Beneficiaries were randomly and equally divided into training, testing, and validation samples. Exposures Potential predictors (n = 268), including sociodemographics, health status, patterns of opioid use, and practitioner-level and regional-level factors, were measured in 3-month windows, starting 3 months before initiating opioids until loss of follow-up or the end of observation. Main Outcomes and Measures Opioid overdose episodes from inpatient and emergency department claims were identified. Multivariate logistic regression (MLR), least absolute shrinkage and selection operator–type regression (LASSO), random forest (RF), gradient boosting machine (GBM), and deep neural network (DNN) were applied to predict overdose risk in the subsequent 3 months after initiation of treatment with prescription opioids. Prediction performance was assessed using the C statistic and other metrics (eg, sensitivity, specificity, and number needed to evaluate [NNE] to identify one overdose). The Youden index was used to identify the optimized threshold of predicted score that balanced sensitivity and specificity. Results Beneficiaries in the training (n = 186 686), testing (n = 186 685), and validation (n = 186 686) samples had similar characteristics (mean [SD] age of 68.0 [14.5] years, and approximately 63% were female, 82% were white, 35% had disabilities, 41% were dual eligible, and 0.60% had at least 1 overdose episode). In the validation sample, the DNN (C statistic = 0.91; 95% CI, 0.88-0.93) and GBM (C statistic = 0.90; 95% CI, 0.87-0.94) algorithms outperformed the LASSO (C statistic = 0.84; 95% CI, 0.80-0.89), RF (C statistic = 0.80; 95% CI, 0.75-0.84), and MLR (C statistic = 0.75; 95% CI, 0.69-0.80) methods for predicting opioid overdose. At the optimized sensitivity and specificity, DNN had a sensitivity of 92.3%, specificity of 75.7%, NNE of 542, positive predictive value of 0.18%, and negative predictive value of 99.9%. The DNN classified patients into low-risk (76.2% [142 180] of the cohort), medium-risk (18.6% [34 579] of the cohort), and high-risk (5.2% [9747] of the cohort) subgroups, with only 1 in 10 000 in the low-risk subgroup having an overdose episode. More than 90% of overdose episodes occurred in the high-risk and medium-risk subgroups, although positive predictive values were low, given the rare overdose outcome. Conclusions and Relevance Machine-learning algorithms appear to perform well for risk prediction and stratification of opioid overdose, especially in identifying low-risk subgroups that have minimal risk of overdose., This prognostic study evaluates the use of machine-learning methods, with prescription drug and claims data, in detecting opioid overdose risk in Medicare beneficiaries with at least 1 opioid prescription.